Be Yourself and Don’t Do It Alone

Episode of the podcast “Conversations Life Science Leaders Aren't Having” with Raphaël G. Ognar, SVP of Global Oncology/Hematology Solutions at Alira Health

The podcast “Conversations Life Science Leaders Aren’t Having” with Jeff Harmon is an opportunity for senior leaders in biotech and pharma to dive into topics that aren’t typically discussed but are keys to success in life, leadership, and in developing life changing solutions for patients around the world.

Raphaël G. Ognar, SVP of Global Oncology/Hematology Solutions at Alira Health, joined the latest episode of “Conversations Life Science Leaders Aren’t Having” to talk about ensuring patient’s well-being while also making life better for colleagues, team members, and even those he passionately disagrees with.

Highlights of the conversation include:

  • Who is Raphael Ognar?
  • Build a Team That’s Not Like You
  • Authentic Leadership
  • The Loneliness of Leadership and Entrepreneurship
  • Creating Human and Business Success
  • WITH vs. FOR the Patient
  • What It Means for the Patient to Live Better
  • Raphael’s “Why” Around Patients
  • Keeping Impact as Top Priority
  • Advice to Fellow CEOs

Listen to the episode “Be Yourself and Don’t Do It Alone” below or check it out on the following platforms:

Watch the episode “Be Yourself and Don’t Do It Alone”:
Listen to the episode:

The episode “Be Yourself and Don’t Do It Alone” is also available on Apple podcast:

Apple podcasts

Multimedia
Published on:
August 24, 2022
Meet our speaker:
Raphael Ognar

Raphaël G. Ognar

SVP of Global Oncology/Hematology Solution, Alira Health

Related news

News January 23, 2023
TerSera Therapeutics to sponsor “NET Cancer Health Storylines” by Alira Health and Carcinoid Cancer Foundation to support patients suffering from Carcinoid Syndrome Diarrhea
We are pleased to announce TerSera Therapeutics’ sponsorship with the Carcinoid Cancer Foundation (CCF) and Alira Health to expand and optimize a holistic patient journey digital(...)
Digital Health Digital Therapeutics Patient Centricity
Multimedia January 12, 2023
The Next Iteration Podcast: Gabriele Brambilla on Leadership, and Work Culture in Europe and the West
Gabriele Brambilla, CEO and Co-Founder of Alira Health, joined The Next Iteration Podcast with hosts Damien Joseph and Fuad Ali to share his experiences of founding and developing Alira(...)
Leadership Life Sciences Teamwork
News January 9, 2023
Alira Health Accelerates Global Growth and Secures Additional $58M Capital Injection
Alira Health, a global healthcare advisory, clinical research and technology company, announced it secured an additional US$58 million in capital funding, further strengthening its(...)
Alira Health Capital Injection Patient Centricity
Publications January 3, 2023
The Future of Healthcare: Patient-Owned Data
A revolution in patient data is upon us at long last...The future we envisioned then is now coming to fruition. This major paradigm shift puts data in the hands of patients, and we are ready for it.
Patient Advocacy Patient Centricity Patient Engagement
Events November 30, 2022
Biotech Showcase
We are pleased to attend Biotech Showcase this year, the investor conference for innovators. This will be the 15th edition of the event and it hosts a wide variety of companies, ranging(...)
Biotech Investor Relations Life Sciences
Publications November 3, 2022
Our Philosophy, Growth, and Future: An Interview with Gabriele Brambilla
In 2015, Alira Health was less than 30 people. Now, we are over 650 all across the world. We sat down with Gabrielle Brambilla, CEO of Alira Health, to find out more about the plan(...)
Innovation Patient Centricity
Multimedia September 8, 2022
HealthBiz Podcast: Interview with Gabriele Brambilla
Gabriele Brambilla, CEO of Alira Health, has joined the HealthBiz podcast to discuss how Alira Health strives to achieve its mission of humanizing healthcare, the importance of seeing(...)
Life Sciences Patient Centricity Product Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.